App-Quantinova.ai

A randomized, placebo controlled, double-blind, phase 4 study to evaluate efficacy and safety of triple anti-platelet therapy compared with dual antiplatelet therapy in patients treated with drug-eluting stent for coronary artery disease

Cheol Hyun Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Rotational atherectomy of malapposed, undilatable coronary stents: fact or fiction?

Istvan F Edes - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Safety and Efficacy of Rotational Atherectomy for the Treatment of Undilatable Underexpanded Stents Implanted in Calcific Lesions

Luca Angelo Ferri - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Long-Term Clinical Outcome of Drug-Eluting Stent Following Rotational Atherectomy for Heavily Calcified Lesions

Hiroyuki Jinnouchi - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes

Oliver Guttmann - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial

Julia Ellert - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes. 5 years follow-up from the COMPARE II trial.

Valeria Paradies - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Clinical outcomes of diabetic patients treated with an amphilimus-eluting stent and a short duration of dual antiplatelet therapy in routine clinical practice: first results of the Utrecht Cre8 (U-Cre8) Registry

Rik Rozemeijer - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Impact of Incomplete Revascularization in Diabetes Mellitus Patients with Multivessel Disease Treated with Percutaneous Coronary Intervention

Sang Yeub Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Prevalence and 5-Year Outcomes of Full Metal Jacket Drug-Eluting Stenting for Coronary Chronic Total Occlusion

Pil Hyung Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CTO Study

Robert Riley - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Ten year follow-up results of left main percutaneous coronary intervention in elderly patients

Ignacio Sanchez-Perez - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Intervention: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaborative Patient-Level Pooled Analysis

Gennaro Giustino - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Three-year clinical outcome of patients treated with the Nobori biolimus-eluting stent and Xience/Promus cobalt-chromium everolimus-eluting stent for unprotected left main disease

Shoichi Kuramitsu - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

High Syntax score and left main percutaneous coronary intervention in high risk patients. Results at a 10 year follow-up

Ignacio Sanchez-Perez - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Long-term Event Free Survival Rates for Successful Chronic Total Occlusions (CTOs) and Matched non-CTO Percutaneous Interventions are Substantially Better than In Persistent CTOs

Matjaz Bunc - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparative efficacy of drug-eluting stents in chronic total occlusions: A report from the SCAAR

Truls Ramunddal - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention

Min Soo Cho - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An analysis of the BASKET-PROVE I and II trials

Tannas Jatene - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Stent fracture and peri-stent contrast staining after everolimus-eluting stent implantation: 5-year clinical outcome

Katsuya Miura - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Filters

7277 Abstracts